Glucose Transporter Type I Deficiency (G1D) at 25 (1990-2015): Presumptions, Facts, and the Lives of Persons With This Rare Disease

Pediatric Neurology

Volumn 53, Issue 5, 2015, Pages 379-393

  Pascual, Juan M ^a   Ronen, Gabriel M ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

blood brain barrier; G1D; Glut1 deficiency; natural history; triheptanoin

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; TRIHEPTANOIN;

BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN METABOLISM; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE BRAIN LEVEL; GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY; HUMAN; KETOGENIC DIET; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RARE DISEASE; REVIEW; SEIZURE; SYNDROME; ADULT; ANIMAL; BRAIN; CASE REPORT; DEFICIENCY; FEMALE; METABOLISM, INBORN ERRORS; PATHOPHYSIOLOGY; RARE DISEASES;

ADULT; ANIMALS; BRAIN; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; METABOLISM, INBORN ERRORS; RARE DISEASES;

EID: 84945485263     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2015.08.001     Document Type: Review

References (125)

1. D. De Vivo, R. Trifiletti, R. Jacobson, and S. Harik Glucose transporter deficiency causing persistent Hypoglycorrhachia: a unique cause of infantile seizures and acquired microcephaly Ann Neurol 29 1990 414 415
2. G.M. Ronen, D.C. De Vivo, and S.I. Harik A second case of defective glucose transport at the blood-brain barrier. Emergence of a novel clinical syndrome Ann Neurol 30 1991 452
3. D.C. De Vivo, R.R. Trifiletti, R.I. Jacobson, G.M. Ronen, R.A. Behmand, and S.I. Harik Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay N Engl J Med 325 1991 703 709
4. E.E. Lee, J. Ma, A. Sacharidou, and et al. A Protein Kinase C Phosphorylation Motif in GLUT1 Affects Glucose Transport and is Mutated in GLUT1 Deficiency Syndrome Mol Cell 58 2015 845 853
5. A. Nehlig, E. Wittendorp-Rechenmann, and C.D. Lam Selective uptake of [14C]2-deoxyglucose by neurons and astrocytes: high-resolution microautoradiographic imaging by cellular 14C-trajectography combined with immunohistochemistry J Cereb Blood Flow Metab 24 2004 1004 1014
6. C. Giaume, A. Tabernero, and J.M. Medina Metabolic trafficking through astrocytic gap junctions Glia 21 1997 114 123
7. R.J. Forsyth Astrocytes and the delivery of glucose from plasma to neurons Neurochem Int 28 1996 231 241
8. J.R. Friedman, E.A. Thiele, D. Wang, and et al. Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet Mov Disord 21 2006 241 245
9. B. Perez-Duenas, C. Prior, Q. Ma, and et al. Childhood chorea with cerebral hypotrophy: a treatable GLUT1 energy failure syndrome Arch Neurol 66 2009 1410 1414
10. A. Roubergue, E. Apartis, V. Mesnage, and et al. Dystonic tremor caused by mutation of the glucose transporter gene GLUT1 J Inherit Metab Dis 34 2011 483 488
11. G. Seidner, M.G. Alvarez, J.I. Yeh, and et al. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier Nat Genet 18 1998 188 191
12. ® [Internet] 2002 University of Washington, Seattle Seattle (WA) 1993 2015 Available at: http://www.ncbi.nlm.nih.gov/books/NBK1430/ Accessed August 1, 2015
13. J.M. Pascual, R.L. Van Heertum, D. Wang, K. Engelstad, and D.C. De Vivo Imaging the metabolic footprint of Glut1 deficiency on the brain Ann Neurol 52 2002 458 464
14. I. Marin-Valencia, L.B. Good, Q. Ma, and et al. Glut1 deficiency (G1D): epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype Neurobiol Dis 48 2012 92 101
15. J. Klepper Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet Epilepsia 49 Suppl 8 2008 46 49
16. L.B. Good, F. Espinosa, Q. Ma, C.W. Heilig, E.T. Kavalali, and J.M. Pascual A neuronal excitability defect in a prototypic energy metabolism disorder American Epilepsy Society annual meeting. Seattle, WA, USA Epilepsia 49 Suppl. 7 2008 364
17. L.B. Good, Q. Ma, E.T. Kavalali, C.W. Heilig, and J.M. Pascual Diminished synaptic quantal amplitudes in a brain energy metabolic disorder. Society for Neuroscience Annual Meeting 2009 Society for Neuroscience Chicago 330.8/H27
18. Marin-Valencia I, Good LB, Ma Q, Arning E, Bottiglieri T, Jeffrey FM, et al. Glycolysis, citric acid cycle flux and neurotransmitter synthesis in mouse brain by 13C NMR spectroscopy Society for Neuroscience Annual Meeting. Chicago2009. p. 406.1.
19. J. Klepper GLUT1 deficiency syndrome in clinical practice Epilepsy Res 100 2012 272 277
20. Y. Kim do, and J.M. Rho The ketogenic diet and epilepsy Curr Opin Clin Nutr Metab Care 11 2008 113 120
21. J.M. Pascual, J. Campistol, and A. Gil-Nagel Epilepsy in inherited metabolic disorders Neurologist 14 2008 S2 S14
22. I. Marin-Valencia, L.B. Good, Q. Ma, C.R. Malloy, and J.M. Pascual Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain J Cereb Blood Flow Metab 33 2013 175 182
23. J.M. Pascual, L.B. Good, P. Liu, and et al. Synaptic excitation-inhibition imbalance in glucose transporter I deficiency (G1D) and first treatment of its associated human epilepsy with triheptanoin. Curing the Epilepsies 2013: Pathways Forward. Bethesda, MD, USA 2013 National Institute of Neurological Disorders and Stroke Bethesda, MD
24. D. Wang, J.M. Pascual, H. Yang, and et al. A mouse model for Glut-1 haploinsufficiency Hum Mol Genet 15 2006 1169 1179
25. S. Ohtsuki, T. Kikkawa, S. Hori, and T. Terasaki Modulation and compensation of the mRNA expression of energy related transporters in the brain of glucose transporter 1-deficient mice Biol Pharm Bull 29 2006 1587 1591
26. C.W. Heilig, T. Saunders, F.C. Brosius 3rd, and et al. Glucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy Proc Natl Acad Sci U S A 100 2003 15613 15618
27. T. Arsov, S.A. Mullen, S. Rogers, and et al. Glucose transporter 1 deficiency in the idiopathic generalized epilepsies Ann Neurol 72 2012 807 815
28. S.A. Mullen, A. Suls, P. De Jonghe, S.F. Berkovic, and I.E. Scheffer Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency Neurology 75 2010 432 440
29. J.M. Pascual, D. Wang, R. Yang, L. Shi, H. Yang, and D.C. De Vivo Structural signatures and membrane helix 4 in GLUT1: inferences from human blood-brain glucose transport mutants J Biol Chem 283 2008 16732 16742
30. D. Wang, J.M. Pascual, H. Yang, and et al. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects Ann Neurol 57 2005 111 118
31. L.D. Leary, D. Wang, D.R. Nordli Jr., K. Engelstad, and D.C. De Vivo Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome Epilepsia 44 2003 701 707
32. J.M. Pascual, D. Wang, V. Hinton, and et al. Brain glucose supply and the syndrome of infantile neuroglycopenia Arch Neurol 64 2007 507 513
33. C.I. Akman, K. Engelstad, V.J. Hinton, and et al. Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency Ann Neurol 67 2010 31 40
34. W.G. Leen, M. Taher, M.M. Verbeek, E.J. Kamsteeg, B.P. van de Warrenburg, and M.A. Willemsen GLUT1 deficiency syndrome into adulthood: a follow-up study J Neurol 261 2014 589 599
35. S.J. Vannucci, R.R. Clark, E. Koehler-Stec, and et al. Glucose transporter expression in brain: relationship to cerebral glucose utilization Dev Neurosci 20 1998 369 379
36. I.A. Simpson, D. Dwyer, D. Malide, K.H. Moley, A. Travis, and S.J. Vannucci The facilitative glucose transporter GLUT3: 20 years of distinction Am J Physiol Endocrinol Metab 295 2008 E242 E253
37. R.B. van Heeswijk, F.D. Morgenthaler, L. Xin, and R. Gruetter Quantification of brain glycogen concentration and turnover through localized 13C NMR of both the C1 and C6 resonances NMR Biomed 23 2010 270 276
38. J.M. Pascual, D. Wang, B. Lecumberri, and et al. GLUT1 deficiency and other glucose transporter diseases Eur J Endocrinol 150 2004 627 633
39. Y. Zhao, C. Fung, D. Shin, B.C. Shin, S. Thamotharan, R. Sankar, and et al. Neuronal glucose transporter isoform 3 deficient mice demonstrate features of autism spectrum disorders Mol Psychiatry 15 2010 286 299
40. M. Guzman, and C. Blazquez Ketone body synthesis in the brain: possible neuroprotective effects Prostaglandins Leukot Essent Fatty Acids 70 2004 287 292
41. H. Brunengraber, and C.R. Roe Anaplerotic molecules: current and future J Inherit Metab Dis 29 2006 327 331
42. G.F. Mason, K.F. Petersen, R.A. de Graaf, G.I. Shulman, and D.L. Rothman Measurements of the anaplerotic rate in the human cerebral cortex using 13C magnetic resonance spectroscopy and [1-13C] and [2-13C] glucose J Neurochem 100 2007 73 86
43. P.J. Magistretti, and L. Pellerin Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging Philos Trans R Soc Lond B Biol Sci 354 1999 1155 1163
44. L. Pellerin, and P.J. Magistretti Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization Proc Natl Acad Sci U S A 91 1994 10625 10629
45. G.F. Mason, R. Gruetter, D.L. Rothman, K.L. Behar, R.G. Shulman, and E.J. Novotny Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR J Cereb Blood Flow Metab 15 1995 12 25
46. G.M. Chowdhury, A.B. Patel, G.F. Mason, D.L. Rothman, and K.L. Behar Glutamatergic and GABAergic neurotransmitter cycling and energy metabolism in rat cerebral cortex during postnatal development J Cereb Blood Flow Metab 27 2007 1895 1907
47. E. Roberts, and S. Frankel gamma-Aminobutyric acid in brain: its formation from glutamic acid J Biol Chem 187 1950 55 63
48. A.B. Patel, R.A. de Graaf, G.F. Mason, D.L. Rothman, R.G. Shulman, and K.L. Behar The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortex In Vivo Proc Natl Acad Sci U S A 102 2005 5588 5593
49. J. Logan Graphical analysis of PET data applied to reversible and irreversible tracers Nucl Med Biol 27 2000 661 670
50. L.F. Barros, C.X. Bittner, A. Loaiza, and O.H. Porras A quantitative overview of glucose dynamics in the gliovascular unit Glia 55 2007 1222 1237
51. I.A. Simpson, A. Carruthers, and S.J. Vannucci Supply and demand in cerebral energy metabolism: the role of nutrient transporters J Cereb Blood Flow Metab 27 2007 1766 1791
52. R. Jolivet, I. Allaman, L. Pellerin, P.J. Magistretti, and B. Weber Comment on recent modeling studies of astrocyte-neuron metabolic interactions J Cereb Blood Flow Metab 30 2010 1982 1986
53. S. Mangia, I.A. Simpson, S.J. Vannucci, and A. Carruthers The In Vivo neuron-to-astrocyte lactate shuttle in human brain: evidence from modeling of measured lactate levels during visual stimulation J Neurochem 109 Suppl 1 2009 55 62
54. H. Lund-Andersen Transport of glucose from blood to brain Physiol Rev 59 1979 305 352
55. B. Hassel, U. Sonnewald, and F. Fonnum Glial-neuronal interactions as studied by cerebral metabolism of [2-13C]acetate and [1-13C]glucose: an Ex Vivo 13C NMR spectroscopic study J Neurochem 64 1995 2773 2782
56. E. Brenner, U. Sonnewald, A. Schweitzer, A. Andrieux, and A. Nehlig Hypoglutamatergic activity in the STOP knockout mouse: a potential model for chronic untreated schizophrenia J Neurosci Res 85 2007 3487 3493
57. M. Yudkoff, Y. Daikhin, I. Nissim, and et al. Response of brain amino acid metabolism to ketosis Neurochem Int 47 2005 119 128
58. I.L. Bogen, O. Risa, K.H. Haug, U. Sonnewald, F. Fonnum, and S.I. Walaas Distinct changes in neuronal and astrocytic amino acid neurotransmitter metabolism in mice with reduced numbers of synaptic vesicles J Neurochem 105 2008 2524 2534
59. C.R. Malloy, A.D. Sherry, and F.M. Jeffrey Carbon flux through citric acid cycle pathways in perfused heart by 13C NMR spectroscopy FEBS Lett 212 1987 58 62
60. I. Marin-Valencia, L.B. Good, Q. Ma, F.M. Jeffrey, C.R. Malloy, and J.M. Pascual High-resolution detection of (13)C multiplets from the conscious mouse brain by Ex Vivo NMR spectroscopy J Neurosci Methods 203 2012 50 55
61. I.E. Holopainen Seizures in the developing brain: cellular and molecular mechanisms of neuronal damage, neurogenesis and cellular reorganization Neurochem Int 52 2008 935 947
62. J.R. Huguenard, and D.A. Prince Intrathalamic rhythmicity studied In Vitro: nominal T-current modulation causes robust antioscillatory effects J Neurosci 14 1994 5485 5502
63. L. Sokoloff The deoxyglucose method for the measurement of local glucose utilization and the mapping of local functional activity in the central nervous system Int Rev Neurobiol 22 1981 287 333
64. P.M. Ullner, A. Di Nardo, J.E. Goldman, and et al. Murine Glut-1 transporter haploinsufficiency: postnatal deceleration of brain weight and reactive astrocytosis Neurobiol Dis 36 2009 60 69
65. J. Smeitink, L. van den Heuvel, and S. DiMauro The genetics and pathology of oxidative phosphorylation Nat Rev Genet 2 2001 342 352
66. S. Dimauro A history of mitochondrial diseases J Inherit Metab Dis 34 2011 261 276
67. R.P. Kinman, T. Kasumov, K.A. Jobbins, and et al. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats Am J Physiol Endocrinol Metab 291 2006 E860 E866
68. L. Gu, G.F. Zhang, R.S. Kombu, and et al. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. II. Effects on lipolysis, glucose production, and liver acyl-CoA profile Am J Physiol Endocrinol Metab 298 2010 E362 E371
69. N. Cholet, L. Pellerin, E. Welker, and et al. Local injection of antisense oligonucleotides targeted to the glial glutamate transporter GLAST decreases the metabolic response to somatosensory activation J Cereb Blood Flow Metab 21 2001 404 412
70. C. Giaume, M. Maravall, E. Welker, and G. Bonvento The barrel cortex as a model to study dynamic neuroglial interaction Neuroscientist 15 2009 351 366
71. J.R. Gibson, A.F. Bartley, S.A. Hays, and K.M. Huber Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome J Neurophysiol 100 2008 2615 2626
72. A. Nehlig Brain uptake and metabolism of ketone bodies in animal models Prostaglandins Leukot Essent Fatty Acids 70 2004 265 275
73. S. Hestrin, P. Sah, and R.A. Nicoll Mechanisms generating the time course of dual component excitatory synaptic currents recorded in hippocampal slices Neuron 5 1990 247 253
74. I. Marin-Valencia, L.B. Good, Q. Ma, C.R. Malloy, M.S. Patel, and J.M. Pascual Cortical metabolism in pyruvate dehydrogenase deficiency revealed by Ex Vivo multiplet (13)C NMR of the adult mouse brain Neurochem Int 61 2012 1036 1043
75. M. Chegary, H. Brinke, J.P. Ruiter, and et al. Mitochondrial long chain fatty acid beta-oxidation in man and mouse Biochim Biophys Acta 1791 2009 806 815
76. W. Yin, E. Carballo-Jane, D.G. McLaren, and et al. Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia J Lipid Res 53 2012 51 65
77. W.G. Bergen, and H.J. Mersmann Comparative aspects of lipid metabolism: impact on contemporary research and use of animal models J Nutr 135 2005 2499 2502
78. E.A. Brunner, S.C. Cheng, and M.L. Berman Effects of anesthesia on intermediary metabolism Annu Rev Med 26 1975 391 401
79. J.K. Penry, and F.E. Dreifuss Automatisms associated with the absence of petit mal epilepsy Arch Neurol 21 1969 142 149
80. J.R. Tenney, and T.A. Glauser The current state of absence epilepsy: can we have your attention? Epilepsy Curr 13 2013 135 140
81. T.A. Glauser, A. Cnaan, S. Shinnar, and et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy N Engl J Med 362 2010 790 799
82. D. Masur, S. Shinnar, A. Cnaan, and et al. Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy Neurology 81 2013 1572 1580
83. J.M. Pascual, L.B. Good, P. Liu, and et al. Synaptic excitation-inhibition imbalance in glucose transporter I deficiency (G1D) and first treatment of its associated human epilepsy with triheptanoin Stroke NIoNDa Curing the Epilepsies 2013 2013 Pathways Forward Bethesda, MD
84. D.A. Gusnard, E. Akbudak, G.L. Shulman, and M.E. Raichle Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function Proc Natl Acad Sci U S A 98 2001 4259 4264
85. C. Heilig, F. Brosius, B. Siu, and et al. Implications of glucose transporter protein type 1 (GLUT1)-haplodeficiency in embryonic stem cells for their survival in response to hypoxic stress Am J Pathol 163 2003 1873 1885
86. A.W. Pong, B.R. Geary, K.M. Engelstad, A. Natarajan, H. Yang, and D.C. De Vivo Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcomes Epilepsia 53 2012 1503 1510
87. E. Posner Pharmacological treatment of childhood absence epilepsy Expert Rev Neurother 6 2006 855 862
88. S.K. Kim, H. Yang, J.M. Pascual, and D.C. De Vivo Valproic acid enhances glucose transport in the cultured brain astrocytes of glucose transporter 1 heterozygous mice J Child Neurol 28 2013 70 76
89. J. Klepper, A. Florcken, J. Fischbarg, and T. Voit Effects of anticonvulsants on GLUT1-mediated glucose transport in GLUT1 deficiency syndrome In Vitro Eur J Pediatr 162 2003 84 89
90. J. Klepper, J. Fischbarg, J.C. Vera, D. Wang, and D.C. De Vivo GLUT1-deficiency: barbiturates potentiate haploinsufficiency In Vitro Pediatr Res 46 1999 677 683
91. Y.Y. Ho, H. Yang, J. Klepper, J. Fischbarg, D. Wang, and D.C. De Vivo Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency In Vitro Pediatr Res 50 2001 254 260
92. D.C. DeVivo, M.P. Leckie, J.S. Ferrendelli, and D.B. McDougal Jr. Chronic ketosis and cerebral metabolism Ann Neurol 3 1978 331 337
93. J. Klepper, H. Scheffer, B. Leiendecker, and et al. Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively Neuropediatrics 36 2005 302 308
94. J. Klepper, B. Leiendecker, R. Bredahl, and et al. Introduction of a ketogenic diet in young infants J Inherit Metab Dis 25 2002 449 460
95. N.R. Sibson, J. Shen, G.F. Mason, D.L. Rothman, K.L. Behar, and R.G. Shulman Functional energy metabolism: In Vivo 13C-NMR spectroscopy evidence for coupling of cerebral glucose consumption and glutamatergic neuronalactivity Dev Neurosci 20 1998 321 330
96. F.M. Jeffrey, I. Marin-Valencia, L.B. Good, and et al. Modeling of brain metabolism and pyruvate compartmentation using C NMR In Vivo: caution required J Cereb Blood Flow Metab 33 2013 1160 1167
97. R.N. Auer, T. Wieloch, Y. Olsson, and B.K. Siesjo The distribution of hypoglycemic brain damage Acta Neuropathol 64 1984 177 191
98. K. Kam, and R. Nicoll Excitatory synaptic transmission persists independently of the glutamate-glutamine cycle J Neurosci 27 2007 9192 9200
99. A.S. Bryant, B. Li, M.P. Beenhakker, and J.R. Huguenard Maintenance of thalamic epileptiform activity depends on the astrocytic glutamate-glutamine cycle J Neurophysiol 102 2009 2880 2888
100. S.L. Liang, G.C. Carlson, and D.A. Coulter Dynamic regulation of synaptic GABA release by the glutamate-glutamine cycle in hippocampal area CA1 J Neurosci 26 2006 8537 8548
101. A. Lutas, and G. Yellen The ketogenic diet: metabolic influences on brain excitability and epilepsy Trends Neurosci 36 2013 32 40
102. M. Yudkoff, Y. Daikhin, T.M. Melo, I. Nissim, U. Sonnewald, and I. Nissim The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect Annu Rev Nutr 27 2007 415 430
103. K. Bough Energy metabolism as part of the anticonvulsant mechanism of the ketogenic diet Epilepsia 49 Suppl 8 2008 91 93
104. S. Kielb, H.P. Koo, D.A. Bloom, and G.J. Faerber Nephrolithiasis associated with the ketogenic diet J Urol 164 2000 464 466
105. W.A. Stewart, K. Gordon, and P. Camfield Acute pancreatitis causing death in a child on the ketogenic diet J Child Neurol 16 2001 682
106. T.H. Best, D.N. Franz, D.L. Gilbert, D.P. Nelson, and M.R. Epstein Cardiac complications in pediatric patients on the ketogenic diet Neurology 54 2000 2328 2330
107. E. Berry-Kravis, G. Booth, A. Taylor, and L.A. Valentino Bruising and the ketogenic diet: evidence for diet-induced changes in platelet function Ann Neurol 49 2001 98 103
108. C.S. Hoyt, and F.A. Billson Optic neuropathy in ketogenic diet Br J Ophthalmol 63 1979 191 194
109. O.E. Owen, A.P. Morgan, H.G. Kemp, J.M. Sullivan, M.G. Herrera, and G.F. Cahill Jr. Brain metabolism during fasting J Clin Invest 46 1967 1589 1595
110. I. Marin-Valencia, S.K. Cho, D. Rakheja, and et al. Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors NMR Biomed 25 2012 1177 1186
111. E.A. Maher, I. Marin-Valencia, R.M. Bachoo, and et al. Metabolism of [U-13 C]glucose in human brain tumors In Vivo NMR Biomed 25 2012 1234 1244
112. I. Marin-Valencia, C. Yang, T. Mashimo, and et al. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain In Vivo Cell Metab 15 2012 827 837
113. I. Marin-Valencia, C.R. Roe, and J.M. Pascual Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis Mol Genet Metab 101 2010 9 17
114. A.H. From, S.D. Zimmer, S.P. Michurski, and et al. Regulation of the oxidative phosphorylation rate in the intact cell Biochemistry 29 1990 3731 3743
115. J. Klepper, and B. Leiendecker Glut1 deficiency syndrome and novel ketogenic diets J Child Neurol 28 2013 1045 1048
116. S.M. Houten, and R.J. Wanders A general introduction to the biochemistry of mitochondrial fatty acid beta-oxidation J Inherit Metab Dis 33 2010 469 477
117. S. Kovac, A.Y. Abramov, and M.C. Walker Energy depletion in seizures: anaplerosis as a strategy for future therapies Neuropharmacology 69 2013 96 104
118. R. Gruetter In Vivo 13C NMR studies of compartmentalized cerebral carbohydrate metabolism Neurochem Int 41 2002 143 154
119. R.F. Addison, and R.G. Ackman Exceptional occurrence of odd-chain fatty acids in smelt (Osmerus mordax) from Jeddore Harbour, Nova Scotia Lipids 5 1970 554 557
120. W. Johnson Jr. Final report on the safety assessment of trilaurin, triarachidin, tribehenin, tricaprin, tricaprylin, trierucin, triheptanoin, triheptylundecanoin, triisononanoin, triisopalmitin, triisostearin, trilinolein, trimyristin, trioctanoin, triolein, tripalmitin, tripalmitolein, triricinolein, tristearin, triundecanoin, glyceryl triacetyl hydroxystearate, glyceryl triacetyl ricinoleate, and glyceryl stearate diacetate Int J Toxicol 20 Suppl 4 2001 61 94
121. J.M. Pascual, P. Liu, D. Mao, and et al. Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement JAMA Neurol 71 2014 1255 1265
122. F. Xu, P. Liu, J.M. Pascual, G. Xiao, H. Huang, and H. Lu Acute effect of glucose on cerebral blood flow, blood oxygenation, and oxidative metabolism Hum Brain Mapp 36 2015 707 716
123. H.T. Chugani, M.E. Phelps, and J.C. Mazziotta Positron emission tomography study of human brain functional development Ann Neurol 22 1987 487 497
124. T. Maejima, P. Wollenweber, L.U. Teusner, J.L. Noebels, S. Herlitze, and M.D. Mark Postnatal loss of P/Q-type channels confined to rhombic-lip-derived neurons alters synaptic transmission at the parallel fiber to purkinje cell synapse and replicates genomic Cacna1a mutation phenotype of ataxia and seizures in mice J Neurosci 33 2013 5162 5174
125. K. Matsushita, M. Wakamori, I.J. Rhyu, and et al. Bidirectional alterations in cerebellar synaptic transmission of tottering and rolling Ca2+ channel mutant mice J Neurosci 22 2002 4388 4398